CRISPR Therapeutics AGCRSPNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank55
3Y CAGR+18.8%
5Y CAGR-21.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+18.8%/yr
vs -17.5%/yr prior
5Y CAGR
-21.2%/yr
Recent acceleration
Acceleration
+36.3pp
Accelerating
Percentile
P55
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $355.19M | +19.1% |
| 2024 | $298.26M | -23.4% |
| 2023 | $389.48M | +83.8% |
| 2022 | $211.88M | -77.0% |
| 2021 | $923.03M | -21.0% |
| 2020 | $1.17B | +23.8% |
| 2019 | $943.77M | +106.7% |
| 2018 | $456.65M | +90.5% |
| 2017 | $239.76M | -24.0% |
| 2016 | $315.52M | - |